4.08 USD
↗ 0.09 (2.36%)LIVE (AS OF 02:57 PM EDT)
Quoin Pharmaceuticals, Ltd. American Depositary Shares
QNRXNASDAQ • USD
Market: OPEN
QNRX is currently priced at $4.08. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place QNRX at a fair price relative to peers.
Technical & fundamental data as of Oct 21, 2026.
Open?$4.03
High?$4.08
Low?$3.93
Prev. Close?$3.99
Volume?11.0K
Avg. Volume?43.3K
VWAP?$4.01
Rel. Volume?0.26x
Bid / Ask
Bid?$3.31 × 100
Ask?$4.86 × 100
Spread?$1.55
Midpoint?$4.09
Valuation & Ratios
Market Cap?19.2M
Shares Out?3.1M
P/E Ratio?N/A
P/B Ratio?4.87
EPS?-$3.89
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
Employees
6
Market Cap
19.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-10-28
Address
23 HATA'AS STREET
KFAR SABA, 44425
Phone: 97299741444
KFAR SABA, 44425
Phone: 97299741444
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?23
Short Sent.?63
Piotroski F-Score?0/9Weak
Altman Z-Score?-12.86Distress
Confidence?50%Low
Short InterestLow
Short Interest?65.5K
Days to Cover?1.4
Avg Daily Volume47.4K
Settlement Date2026-09-30
Financial Health
Current Ratio?1.76Adequate
Quick Ratio?1.76Adequate
Cash Ratio?0.58Adequate
Debt/Equity?0.29Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?4.87FAIR▾
Peers100
S&P38
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.9CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-474.6%WEAK▾
S&P3
ROA?-155.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-15273747
Enterprise Value?$16.5M
Fundamentals ratios updated end of day